Delivery Order SPE2DB20D9335-SPE2DB25FW3V7
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,410.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. The award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,544.60 for Typhoid VI Polysaccharide vaccine on July 23, 2025, with an ultimate completion date of August 4, 2025. This delivery order was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The award represents a continuation of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,079 contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine product, with a completion date of July 18, 2025. DMS Pharmaceutical Group has a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999...
- This federal contract award is a delivery order valued at $11,263.20 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a specialized pharmaceutical product, with a completion date of December 20, 2024. The award is not associated with a set-aside designation and is a firm fixed-price delivery order. DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,564,220,848 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The $1,748.69 delivery order was issued under DMS Pharmaceutical's $4,999,999 indefinite delivery vehicle (IDV) contract SPE2DB with DLA to supply a broad range of pharmaceutical items to U.S. military medical facilities worldwide. This contract award does not...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,038.80 under an indefinite delivery contract with the Defense Logistics Agency to supply typhoid VI polysaccharide vaccine. As a woman-owned small business, DMS Pharmaceutical Group will deliver the vaccines to the Park Ridge, Illinois facility of the Defense Logistics Agency Troop Support Medical organization. This delivery order was issued against DMS Pharmaceutical Group's existing pharmaceutical prime...
- This is a $156,063.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Typhoid VI Polysaccharide vaccine (CLIN 8510672632) with a completion date of June 18, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $1,854.46, is a delivery order for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 17, 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,038.80 under an indefinite delivery contract with the Defense Logistics Agency to supply typhoid VI polysaccharide vaccine. As a woman-owned small business, DMS Pharmaceutical will deliver the specified vaccines to the Defense Logistics Agency Troop Support Medical facility in Park Ridge, Illinois by February 28, 2020. This delivery order was issued against DMS Pharmaceutical's existing pharmaceutical prime...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,038.80 under an indefinite delivery contract with the Defense Logistics Agency to supply typhoid VI polysaccharide vaccines. As a woman-owned small business, DMS Pharmaceutical Group will deliver the vaccines to the Defense Logistics Agency Troop Support Medical facility in Park Ridge, Illinois by October 24, 2018. The delivery order was issued without a set-aside designation against DMS Pharmaceutical...
- SPE2DB20D9335Indefinite Delivery Contract
- SPE2DB20D9335-SPE2DB25FW3V7Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $7,410 firm fixed-price delivery order by the Defense Logistics Agency on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract calls for the delivery of TYPHIM VI 25 MCG/0.5 ML syringes—a typhoid conjugate vaccine used for immunization purposes—to support Department of Defense healthcare requirements. This delivery order was issued without a set-aside designation, demonstrating the company's competitive standing in federal procurement markets. This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The parent IDC enables the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including vaccines, injections, prescription medications, biologics, and medical consumables to military health facilities. This delivery order for TYPHIM VI vaccine represents a routine procurement from DMS Pharmaceutical Group's extensive pharmaceutical supply portfolio supporting the Defense Logistics Agency's medical supply distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 8/4/25 |